Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bartlmanon Jun 23, 2018 3:15pm
139 Views
Post# 28218813

RE:AGM meeting part 2

RE:AGM meeting part 2Harpos just want to thank you for your excellent reporting, never mind risking your life to get to the meeting. You are a world class (and classy) dude. The information on financing seems particularly relevant since that seems to be what has everyone's knickers in a knot.

As someone suggested (perhaps you yourself) there should be no need to raise $30 million up front. It will likely come in tranches. Now, if the company is smart - and I think they're real smart - they will be doing everything posssible to keep the share price up so that each money raise will be at a higher price. Conceivably, with some expected good news, share prices could exceed a buck meaning at most a 30 million share addition. It could be even better than that.

I do believe that Federal and even Provincial grants should be explored (private foundations as well). One of the other companies I follow is Biolargo (BLGO) an American company working with Canadian developed technology. They have been in receipt of numerous Federal and Provincial grants as they develop a new water purification technology, in fact, grants well in excess of what TLT is seeking. Canadian developed technology should be supported - the payoff and payout would be enormous for the country.
Bullboard Posts